The choice of a noninformative prior on between-study variance strongly affects predictions of future treatment effect

Medical Decision Making

Volumn 33, Issue 3, 2013, Pages 356-368

  Gajic Veljanoski, Olga ^a,b   Cheung, Angela M ^a,b,d   Bayoumi, Ahmed M ^a,d,e   Tomlinson, George ^a,c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Bayesian methods; between study variance; goodness of fit; noninformative priors; predictions; random effects meta analysis

Indexed keywords

ARTICLE; BAYES THEOREM; THEORETICAL MODEL;

BAYES THEOREM; MODELS, THEORETICAL;

EID: 84875731412     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X12453504     Document Type: Article

References (41)

1. Spiegelhalter DJ, Abrams KR, Myles JP Chichester, UK: John Wiley & Sons ; 2004 :
2. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR Chichester, UK: John Wiley & Sons ; 2009 :
3. Higgins JP, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc. 2009 ; 172 (1). 137-59
4. Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F Chichester, UK: John Wiley & Sons ; 2000 :
5. Riley RD, Higgins JP, Deeks JJ. Interpretation of random effects meta-analyses. BMJ. 2011 ; 342: d549
6. Ades AE, Lu G, Higgins JP. The interpretation of random-effects meta-analysis in decision models. Med Decis Making. 2005 ; 25 (6). 646-54
7. Ades AE, Welton NJ, Caldwell D, Price M, Goubar A, Lu G. Multiparameter evidence synthesis in epidemiology and medical decision-making. J Health Serv Res Policy. 2008 ; 13: 12-22
8. Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ. 1999 ; 18 (3). 341-64
9. Claxton K, Thompson KM. A dynamic programming approach to the efficient design of clinical trials. J Health Econ. 2001 ; 20 (5). 797-822
10. Willan AR, Eckermann S. Accounting for between-study variation in incremental net benefit in value of information methodology. Health Econ.. 2011 ;:
11. Welton N, Ades AE. Research decisions in the face of heterogeneity: what can a new study tell us?. Health Econ Sep. 2011 2011 ;:
12. Wijeysundera DN, Austin PC, Hux JE, Beattie WS, Laupacis A. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials. J Clin Epidemiol. 2009 ; 62 (1). 13-21
13. Kass RE, Wasserman L. The selection of prior distributions by formal rules. J Am Stat Assoc. 1996 ; 91: 1343-70
14. Lambert PC, Sutton AJ, Burton PR, Abrams KR, Jones DR. How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS. Stat Med. 2005 ; 24 (15). 2401-28
15. Gelman A. Prior distributions for variance parameters in hierarchical models. Bayesian Analysis. 2006 ; 1 (3). 515-33
16. Pullenayegum E. An informed reference prior for between-study heterogeneity in meta-analyses of binary outcomes. Stat Med. 2011 ; 30 (26). 3082-94
17. Ades AE. ISPOR states its position on network meta-analysis. Value Health. 2011 ; 14 (4). 414-16
18. Bohning D, Malzahn U, Dietz E, Schlattmann P, Viwatwongkasem C, Biggeri A. Some general points in estimating heterogeneity variance with the DerSimonian-Laird estimator. Biostatistics. 2002 ; 3 (4). 445-57
19. Colditz GA, Burdick E, Mosteller F. Heterogeneity in meta-analysis of data from epidemiologic studies: a commentary. Am J Epidemiol. 1995 ; 142 (4). 371-82
20. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002 ; 21 (11). 1539-58
21. AvenellAGillespieWJGillespieLDO'ConnellD. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev. 2009;(2):CD000227. Available at: URL: http://www2.cochrane.org/ reviews/en/ab000227.html
22. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, wson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA. 2005 ; 293 (18). 2257-64
23. SpinksAGlasziouPPDel MarCB. Antibiotics for sore throat. Cochrane Database Syst Rev. 2006;(4):CD000023. Available at: URL: http://www2.cochrane. org/reviews/en / ab000023.html
24. Cranney A, Horsley T, O'Donnell S, et al. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep). 2007 ; (158). 1-235
25. MacLennanAHBJLLesterSMooreV. The effect of oral oestrogen and combined oestrogen/progesterone therapy versus placebo for hot flushes. Cochrane Database Syst Rev.2004(4):CD002978. Available at: URL: http://www2.cochrane.org/reviews/ en/ ab002978.html
26. Spiegelhalter DJ, Abrams KR, Myles JP Bayesian Approaches to Clinical Trials and Health-Care Evaluation. Spiegelhalter DJ Abrams KR Myles JP, ed. Chichester, UK: John Wiley & Sons ; 139-80.
27. Ades AE, Cliffe S. Markov chain Monte Carlo estimation of a multiparameter decision model: consistency of evidence and the accurate assessment of uncertainty. Med Decis Making. 2002 ; 22 (4). 359-71
28. Spiegelhalter DJ, Best NG, Carlin BP, van der Linde A. Bayesian measures of model complexity and fit. J R Stat Soc B. 2002 ; 64 (4). 583-639
29. DIC: Deviance Information Criterion. Available from: URL: http://www.mrc-bsu.cam.ac.uk/bugs/winbugs/dicpage.shtml#q1. Accessed 13 October 2011.
30. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996 ; 15 (4). 361-87
31. Kleinbaum DG, Kupper LL, Muller KE, Nizam A 3 rd ed.Pacific Grove, CA: Brooks/Cole; 1998. Pacific Grove, CA: Brooks/Cole ; 1998 :
32. Steyerberg EW, Harrell FE, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol. 2001 ; 54 (8). 774-81
33. Ades AE. A chain of evidence with mixed comparisons: models for multi-parameter synthesis and consistency of evidence. Stat Med. 2003 ; 22 (19). 2995-3016
34. Marshall EC, Spiegelhalter DJ. Approximate cross-validatory predictive checks in disease mapping models. Stat Med. 2003 ; 22 (10). 1649-60
35. Lunn DJ, Thomas A, Best N, Spiegelhalter D. WinBUGS - a Bayesian modelling framework: concepts, structure, and extensibility. Stat Comput. 2000 ; 10: 325-37
36. Brooks S, Gelman A. Alternative methods for monitoring convergence of iterative simulations. J Comput Graph Stat. 1998 ; 7: 434-55
37. Daniels MJ. A prior for the variance in hierarchical models. Can J Stat. 1999 ; 27 (3). 569-80
38. Senn S. Trying to be precise about vagueness. Stat Med. 2007 ; 26 (7). 1417-30
39. Farrell PJ, MacGibbon BTTJ. Protection against outliers in empirical Bayes estimation. Can J Stat. 1994 ; 22 (3). 365-76
40. O'Hagan A, Stevens JW. Bayesian assessment of sample size for clinical trials of cost-effectiveness. Med Decis Making. 2001 ; 21 (3). 219-30
41. O'Hagan A. Science, Subjectivity and software (comment on articles by Berger and by Goldstein). Bayesian Analysis. 2006 ; 1 (2). 445-50